THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
<p><em>Background: </em>Relatively little information on secondary cancers is available for Non-Hodgkin lymphoma (NHL) treated patients as treatments have been less effective compared to those for Hodgkin Lymphoma. Recently, evolving chemotherapy (CHT) in co...
Saved in:
| Main Authors: | Raffaella Marcheselli, Eliana Valentina Liardo, Luigi Marcheselli, Alessia Bari, Samantha Pozzi, Stefano Sacchi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2011-01-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | http://www.mjhid.org/article/view/9557 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
First research of use Vero-Fludarabine in chronic lymphocytic leukemia and non-hodgkins lymphoma
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01) -
Lower Number of Fludarabine Cycles in Patients with Lymphoid Malignancies
by: Donald Pasquale
Published: (2014-08-01) -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
by: Luca Laurenti, et al.
Published: (2010-08-01) -
Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
by: E. V. Kataeva, et al.
Published: (2014-07-01) -
Initial renal function and type of chemotherapy: impact on treatment efficacy in patients with chronic lymphocytic leukemia
by: A. K. Nikitina, et al.
Published: (2015-06-01)